BioBreakthroughs

Our Guest: Richard Brandon, Chief Scientific Officer at Immunexpress

What you'll get out of this episode:
  • Richard's background
  • Overview of Immunexpress
  • The impact of a lack of reliable sepsis diagnostics
  • SeptiCyte technology
  • What's next?

Our sponsors for this episode are Sage Growth Partners

Sage Growth Partners accelerates commercial success for healthcare organizations through a singular focus on growth. The company helps its clients thrive amid the complexities of a rapidly changing marketplace with deep domain expertise and an integrated application of research, strategy, and marketing. For more information, please go to www.sage-growth.com & follow Sage Growth Partners on social media - @sagegrowthpartners

Learn more about Immunexpress follow these links: 
LinkedIn - Website 

Also, be sure to follow Slice of Healthcare on our social channels:
Website  - LinkedIn - Twitter - YouTube - Newsletter


What is BioBreakthroughs?

Welcome to BioBreakthroughs, the podcast that delves deep into the world of biotech and pharmaceuticals to bring you the latest and most exciting advancements in the field. Join us as we explore groundbreaking discoveries, cutting-edge research, and game-changing innovations that are shaping the future of healthcare. Produced by Slice of Healthcare.